CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling
Castration resistance is a major obstacle to hormonal therapy for prostate cancer patients. Although androgen independence of prostate cancer growth is a known contributing factor to endocrine resistance, the mechanism of androgen receptor deregulation in endocrine resistance is still poorly underst...
Main Authors: | Wang, Tao, Guo, Shuiming, Liu, Zhuo, Wu, Licheng, Li, Mingchao, Yang, Jun, Chen, Ruibao, Liu, Xiaming, Xu, Hua, Cai, Shaoxin, Chen, Hui, Li, Weiyong, Xu, Shaohua, Wang, Liang, Hu, Zhiquan, Zhuang, Qianyuan, Wang, Liping, Wu, Kongming, Liu, Jihong, Ye, Zhangqun, Ji, Jun-Yuan, Wang, Chenguang, Chen, Ke |
---|---|
Format: | Online |
Language: | English |
Published: |
Impact Journals LLC
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279373/ |
Similar Items
-
The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancer
by: Wang, Tao, et al.
Published: (2014) -
AR Pathway Is Involved in the Regulation of CX43 in Prostate Cancer
by: Chen, Ruibao, et al.
Published: (2015) -
AB061. Clinical analysis of small cell carcinoma of the bladder: 9 cases report and literature review
by: Chen, Zhi, et al.
Published: (2016) -
Laparoscopic versus Open Radical Cystectomy in Bladder Cancer: A Systematic Review and Meta-Analysis of Comparative Studies
by: Tang, Kun, et al.
Published: (2014) -
AB194. Human tissue kallikrein 1 attenuates histomorphological of penile corpus cavernosum in the streptozotocin-induced diabetic rats
by: Luan, Yang, et al.
Published: (2015)